|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1985-4-26
|
|
pubmed:abstractText |
A randomised comparison is made between methylprednisolone, 1 g intravenously daily for 7 days, and a standard ACTH regime for the treatment of multiple sclerosis in acute relapse. It is found that methylprednisolone produces a more rapid clinical improvement than ACTH but confers no longer term benefit when the two treatments are compared at 3 months. It is proposed that intravenous methylprednisolone does have a role to play in the management of a patient with an acute relapse of multiple sclerosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0022-3050
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
157-9
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2984332-Adrenocorticotropic Hormone,
pubmed-meshheading:2984332-Adult,
pubmed-meshheading:2984332-Clinical Trials as Topic,
pubmed-meshheading:2984332-Female,
pubmed-meshheading:2984332-Humans,
pubmed-meshheading:2984332-Injections, Intramuscular,
pubmed-meshheading:2984332-Injections, Intravenous,
pubmed-meshheading:2984332-Male,
pubmed-meshheading:2984332-Methylprednisolone,
pubmed-meshheading:2984332-Middle Aged,
pubmed-meshheading:2984332-Multiple Sclerosis,
pubmed-meshheading:2984332-Random Allocation,
pubmed-meshheading:2984332-Recurrence,
pubmed-meshheading:2984332-Time Factors
|
|
pubmed:year |
1985
|
|
pubmed:articleTitle |
Intravenous methylprednisolone for multiple sclerosis in relapse.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
